Naughton Gail K has filed 4 insider transactions across 2 companies since August 2023.
Most recent transaction: a grant/award of 8500 shares of TherapeuticsMD, Inc. ($TXMD) on November 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 3, 2025 | TherapeuticsMD, Inc. | $TXMD | Naughton Gail K | Not found | A | Restricted Stock Units | 8500 | $0.00 | 8,500.0000 | 11,574,000 | 9999.99% | 0.07% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Naughton Gail K | Not found | M | Common Stock | 8500 | $0.00 | 8,500.0000 | 11,532 | 9999.99% | 73.71% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Naughton Gail K | Not found | M | Restricted Stock Units | 8500 | $0.00 | 0.0000 | 11,532 | 100.00% | 73.71% |
| Aug. 8, 2023 | CEL SCI CORP | $CVM | Naughton Gail K | Director | A | Options | 85000 | $0.01 | 149,000.0000 | 0 | 132.81% | 0.00% |